cost effectiveness of restricting tv food ads targeting children

1
PharmacoEconomics & Outcomes News 593 - 12 Dec 2009 Cost effectiveness of restricting TV food ads targeting children Australian research suggests that restricting TV advertisements targeting children could be "one of the most cost-effective population-based obesity prevention interventions available to governments today". An economic analysis, conducted as part of the Assessing Cost-Effectiveness in Obesity (ACE-Obesity) project, investigated the health benefits and cost effectiveness of precluding advertising of energy-dense, nutrient-poor (EDNP) food and beverages during peak children’s TV viewing hours. Benefits were modelled in terms of changes in body mass index (BMI) and disability-adjusted life years (DALYs) saved. The impact of the intervention was estimated using the best available evidence, which included trials investigating the effects of behavioural interventions on food consumption, as well as parallel evidence of behavioural changes resulting from reductions in advertising of other products, such as toys, tobacco and alcohol. The target population was all children aged 5–14 years in Australia in 2001 (2.4 million children). The total cost of the intervention was $A130 000, * which was the cost of two additional staff required to monitor the tightened regulatory framework. The health benefit was estimated as a median BMI reduction of 0.17 per child, or 0.014 DALYs saved per child. The gross cost per DALY saved was $3.70 (95% CI $2.40, $7.70). Given cost offsets, assessed in terms of future health sector costs saved, of $300 million, the intervention was considered dominant compared with current practice. * Australian dollars Magnus A, et al. The cost-effectiveness of removing television advertising of high- fat and/or high-sugar food and beverages to Australian children. International Journal of Obesity 33: 1094-1102, No. 10, Oct 2009 801129861 1 PharmacoEconomics & Outcomes News 12 Dec 2009 No. 593 1173-5503/10/0593-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: trancong

Post on 16-Mar-2017

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Cost effectiveness of restricting TV food ads targeting children

PharmacoEconomics & Outcomes News 593 - 12 Dec 2009

Cost effectiveness of restricting TVfood ads targeting children

Australian research suggests that restricting TVadvertisements targeting children could be "one of themost cost-effective population-based obesity preventioninterventions available to governments today".

An economic analysis, conducted as part of theAssessing Cost-Effectiveness in Obesity (ACE-Obesity)project, investigated the health benefits and costeffectiveness of precluding advertising of energy-dense,nutrient-poor (EDNP) food and beverages during peakchildren’s TV viewing hours. Benefits were modelled interms of changes in body mass index (BMI) anddisability-adjusted life years (DALYs) saved. The impactof the intervention was estimated using the bestavailable evidence, which included trials investigatingthe effects of behavioural interventions on foodconsumption, as well as parallel evidence of behaviouralchanges resulting from reductions in advertising of otherproducts, such as toys, tobacco and alcohol. The targetpopulation was all children aged 5–14 years in Australiain 2001 (2.4 million children).

The total cost of the intervention was $A130 000,*which was the cost of two additional staff required tomonitor the tightened regulatory framework. The healthbenefit was estimated as a median BMI reduction of0.17 per child, or 0.014 DALYs saved per child. Thegross cost per DALY saved was $3.70 (95% CI $2.40,$7.70). Given cost offsets, assessed in terms of futurehealth sector costs saved, of $300 million, theintervention was considered dominant compared withcurrent practice.* Australian dollars

Magnus A, et al. The cost-effectiveness of removing television advertising of high-fat and/or high-sugar food and beverages to Australian children. InternationalJournal of Obesity 33: 1094-1102, No. 10, Oct 2009 801129861

1

PharmacoEconomics & Outcomes News 12 Dec 2009 No. 5931173-5503/10/0593-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved